The short version of REV-ERB agonist fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-04-21. Anything still debated is marked as such rather than presented as settled.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | SR9009; Stenabolic | Nickname is not a chemical name. |
| Typical analytical method | LC-MS/MS | Often with isotope-labeled internal standard. |
| Storage temperature | -20 °C | Desiccated and protected from light. |
| Solution stability | DMSO stock; avoid freeze-thaw | Store at -20 to -80 °C. |
| Regulatory status | Not approved; varies by country | May be restricted as research chemical. |
Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.
Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.
Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.
REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
=== First allegation of domestic abuse === In October 2020, Zverev's ex-girlfriend Olga Sharypova, in an article in Racquet magazine by journalist Ben Rothenberg, accused Zverev of physically and emotionally abusing her over the course of their relationship. Sharypova named multiple instances where Zverev allegedly became violent towards her, including punching her in the face during an argument that took place in the pair's hotel room while Zverev was competing at the 2019 Laver Cup. Zverev denied the allegations and issued a statement after Sharypova's initial accusations: "I very much regret that she makes such statements. Because the accusations are simply not true." A second article by Rothenberg about the allegations was released in August 2021, this time in Slate magazine. The second article picked up Sharypova's story where the first left off. It includes this description of the alleged violence escalating in October 2019:
The two substrates of this enzyme are (R,R)-butane-2,3-diol and NAD+; its products are (R)-acetoin, nicotinamide adenine dinucleotide (NADH), and a proton. This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-OH group of donor with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is (R,R)-butane-2,3-diol:NAD+ oxidoreductase. Other names in common use include butyleneglycol dehydrogenase, D-butanediol dehydrogenase, D-(−)-butanediol dehydrogenase, butylene glycol dehydrogenase, diacetyl (acetoin) reductase, D-aminopropanol dehydrogenase, D-aminopropanol dehydrogenase, 1-amino-2-propanol dehydrogenase, 2,3-butanediol dehydrogenase, D-1-amino-2-propanol dehydrogenase, (R)-diacetyl reductase, (R)-2,3-butanediol dehydrogenase, D-1-amino-2-propanol:NAD+ oxidoreductase, 1-amino-2-propanol oxidoreductase, and aminopropanol oxidoreductase. This enzyme participates in butanoic acid metabolism.
=== First measures === Right after taking office on 1 January 2023, Lula and his ministers took several measures to revert Bolsonaro policies and/or create policies announced during the election campaign and the transition of power. This processs, known as "desbolsonarização" (de-'Bolsonarization') or "revogaço" (mass repeal of decrees) by some ministers and party members included a series of federal decrees revoking the previous government's measures involving weapons, environment policies and top officials' data secrecy. Some of the decrees included temporarily suspending new authorizations for shooting clubs, revoking Bolsonaro government policies that allowed "artisan mining" in the Amazon rainforest area and indigenous lands (which were seen as an incentive to illegal miners). and the creation of the "Secretary of Digital Policies", which was to be established under the Secretary of Social Communications with the stated objective of "combatting the spread of disinformation, fake news and hate speech on the internet". On the same week, Environment and Climate Change Minister Marina Silva claimed that another "revogaço" was yet to come. Mostly related to the teto de gastos (debt ceiling) fiscal policy, which was seen as impractical by government officials. This policy was later replaced with another debt limit law following its approval in the Federal Congress.
Channels: Channels are either in open state or closed state. When a channel is opened with a slight conformational switch, it is open to both environment simultaneously (extracellular and intracellular)
Sources: en.wikipedia.org
Uranium-238 (238U or U-238) is the most common isotope of uranium in nature. It is not fissile, but is fertile: it can capture a slow neutron and after two beta decays become fissile plutonium-239. Uranium-238 is fissionable by fast neutrons, but cannot support a chain reaction because inelastic scattering reduces neutron energy below the range where fast fission of one or more next-generation nuclei is probable. Doppler broadening of 238U's neutron absorption resonances, increasing absorption as fuel temperature increases, is an essential negative feedback mechanism for reactor control. About 99.274% of natural uranium is uranium-238, which has a half-life of 4.463×109 years. Depleted uranium has an even higher concentration of 238U, and even low-enriched uranium (LEU) is still mostly 238U. Reprocessed uranium is also mainly 238U, with about as much uranium-235 as natural uranium, a comparable proportion of uranium-236, and much smaller amounts of other isotopes of uranium such as uranium-234, uranium-233, and uranium-232.
Zinc-complexed insulins continued to be used for slow-release basal support, covering approximately 50% of daily insulin needs, while mealtime insulin made up the remaining half. The development of monomeric insulins addressed the limitations of hexameric formulations, ensuring faster absorption and better glycemic control. As research progressed, insulin analogues with enhanced receptor binding, extended duration, and improved stability became standard in modern diabetes treatment, reducing variability in glucose levels and lowering the risk of hypoglycemia.
=== 7-12 August 2008 === On 7 August, the Georgian Foreign Ministry issued a statement holding Russia responsible and stating that Russia must compel South Ossetian separatists to cease artillery attacks on Georgian villages and Russian military assistance of the separatists was "yet another act of aggression against Georgia." One hour before the advance of Georgian troops on Tskhinvali on late 7 August 2008, deputy foreign minister Grigol Vashadze told Interfax that the South Ossetian regime might not attend peace talks scheduled in Tskhinvali on 8 August because the Ossetian regime needed the conflict. He further stated: "For fifteen years, we are drawing attention to the fact that the technical, material and military resources arrive in the Tskhinvali region through the Roki Tunnel. But the peacemakers, instead of acting to demilitarise the region, were turning a blind eye." On 7 August 2008, Assistant Secretary of State Daniel Fried said: "It appears that the South Ossetians have instigated this uptick in violence. We have urged the Russians to urge their South Ossetian friends to pull back and show greater restraint." Fried did not suspect the Russians of inciting the South Ossetians to violence. On 8 August 2008, Georgian minister Temur Iakobashvili said that Georgia intended to eliminate "a criminal regime". On 8 August 2008, Swedish Minister for Foreign Affairs Carl Bildt said that the crisis was due to provocations from the South Ossetian side and that Georgian forces were trying to restore the constitutional order.
Sources: en.wikipedia.org
== Medical uses == Clascoterone is indicated for the topical treatment of acne vulgaris in people aged twelve years of age and older. Two large phase III randomized controlled trials evaluated the effectiveness of clascoterone for the treatment of acne over a period of 12 weeks. Clascoterone decreased acne symptoms by about 8 to 18% more than placebo. The defined treatment success endpoint was achieved in about 18 to 20% of individuals with clascoterone relative to about 7 to 9% of individuals with placebo. The comparative effectiveness of clascoterone between males and females was not described.
=== Ontogeny and life history === Neanderthal brain size at birth was similar to modern humans and constrained by the same obstetric factors; mothers giving birth to infants with heads too large to pass through the birth canal would be selected against. Growth in brain volume occurred at a faster pace in Neanderthal infants than in modern human infants, but growth of the brain did not reach completion earlier in Neanderthals than in modern humans owing to the larger brain size of the former. The rate of incisor crown formation in Neanderthals is also indicative of an accelerated pattern of life history relative to modern humans. Estimates of the age at weaning of Neanderthals vary. Barium levels in the enamel of a Belgian Neanderthal tooth from Scladina suggest a weaning age of 1.2 years. Trace element analysis of a Neanderthal tooth from Payre suggests that weaning occurred at about 2.5 years of age.
=== Cancer === In 2015, the International Agency for Research on Cancer (IARC) classified unprocessed red meat as "probably carcinogenic to humans (Group 2A)". To make this classification, the IARC Working Group assessed over 800 epidemiological studies in addition to other types of studies such as animal bioassays. When assessing whether substances are carcinogenic to humans, it is rare for data from randomized trials to be available. The Working Group found "limited" epidemiological evidence linking unprocessed red meat to colorectal, pancreatic, and prostate cancer. Additionally, it found "strong mechanistic evidence" that unprocessed red meat is carcinogenic. Mechanistic evidence is evidence of plausible biological pathways in which a substance could cause cancer. For instance, studies had found that participants who had recently eaten red meat had higher levels of carcinogenic N-nitroso compounds in their guts and feces. For processed red meat, evidence of harm is stronger. The IARC classified processed meat as carcinogenic to humans (Group 1), based on "sufficient evidence in humans that the consumption of processed meat causes colorectal cancer." The American Institute for Cancer Research, Cancer Research UK and World Cancer Research Fund International have supported these conclusions. More recent meta-analyses have further supported the finding that high consumption of red meat is associated with increased risk of gastrointestinal cancer.
==== Use of booby-trapped devices ==== Experts warned the 2024 Lebanon electronic device attacks potentially violated international humanitarian law. Josep Borrell, the European Union's High Representative for Foreign Affairs and Security Policy, questioned the legality of the pager attacks due to their high collateral damage among civilians, including the deaths of children. Jeanine Hennis-Plasschaert, the United Nations Special Coordinator for Lebanon, also raised concerns that the attacks were illegal. Belgian deputy prime minister Petra De Sutter went further, calling it a "terror attack". Volker Turk, the UN human rights chief, stated, "International humanitarian law prohibits the use of booby-trap devices in the form of apparently harmless portable objects". Booby traps are mostly outlawed under the Protocol on Mines, Booby-Traps and Other Devices ("Amended Protocol II") of the Convention on Certain Conventional Weapons, to which Israel is a party. Article 7, paragraph 2 of Amended Protocol II prohibits the use of "booby-traps or other devices in the form of apparently harmless portable objects which are specifically designed and constructed to contain explosive material." The rules of engagement of some countries, such as the United Kingdom, also ban explosive devices disguised as harmless items.
Sources: en.wikipedia.org
The most common approach is liquid chromatography-tandem mass spectrometry, often after extraction from blood, urine, or tissue. Ultraviolet detection and nuclear magnetic resonance spectroscopy are used mainly for reference material characterization. Isotope-labeled internal standards improve accuracy.
Solid material is usually kept at -20 °C, desiccated, and protected from light. Dimethyl sulfoxide stocks should be stored cold and subjected to minimal freeze-thaw cycles. Aqueous solutions are generally less stable and should be prepared fresh when possible.
Legality depends on the country and the intended use. It is not an approved medicine, and some places restrict or ban sales for human consumption. Buyers should verify local rules and product documentation before procurement.
It is a synthetic research compound that activates REV-ERB nuclear receptors. It is not an approved drug or dietary supplement. Most information comes from cell and animal studies.